ArticleClinical and translational medicine2023
Correction to: BCL2L2 loss renders -14q renal cancer dependent on BCL2L1 that mediates resistance to tyrosine kinase inhibitors.
Yinfeng Lyu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.